Lunai Bioworks Inc. (LNAI)
OTCMKTS · Delayed Price · Currency is USD
0.1648
-0.0713 (-30.20%)
At close: Oct 29, 2026
Lunai Bioworks Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1.71 | 0.09 | 0.22 | 1.87 | 9.17 |
Short-Term Investments | - | 0.39 | - | - | - |
Cash & Short-Term Investments | 1.71 | 0.48 | 0.22 | 1.87 | 9.17 |
Cash Growth | 256.60% | 117.97% | -88.24% | -79.56% | -55.61% |
Other Receivables | - | - | 1.11 | - | - |
Receivables | - | - | 1.11 | - | - |
Prepaid Expenses | 0.32 | 0.57 | 0.67 | 0.69 | 0.39 |
Total Current Assets | 2.04 | 1.05 | 2 | 2.57 | 9.57 |
Property, Plant & Equipment | 0.01 | 1.06 | 1.75 | 1.42 | 1.74 |
Goodwill | 5.96 | 5.96 | 159.33 | 11.64 | 11.64 |
Other Intangible Assets | 1.93 | 0.17 | 0.03 | 42.65 | 61.62 |
Other Long-Term Assets | - | - | 0.02 | 0.02 | 0.07 |
Total Assets | 9.94 | 8.23 | 163.13 | 58.3 | 84.63 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 12.39 | 12.56 | 9.45 | 5.3 | 1.4 |
Accrued Expenses | 5.02 | 5.84 | 5.31 | 0.72 | 1.03 |
Short-Term Debt | 0.54 | 3.58 | - | 0.18 | - |
Current Portion of Long-Term Debt | 0.6 | 5.86 | 2.45 | 4.62 | 1.2 |
Current Portion of Leases | 0.29 | 0.31 | 0.49 | 0.19 | 0.25 |
Other Current Liabilities | 0.07 | 1.01 | 12.61 | - | 2.56 |
Total Current Liabilities | 18.91 | 29.16 | 30.31 | 11.02 | 6.45 |
Long-Term Debt | - | - | - | - | 4.58 |
Long-Term Leases | 0.06 | 0.42 | 0.84 | 0.78 | 0.99 |
Total Liabilities | 18.97 | 29.58 | 31.15 | 11.8 | 12.01 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 0 | 0 | 0.02 | 0.01 | 0.01 |
Additional Paid-In Capital | 505.16 | 478.3 | 464.59 | 290.55 | 276.99 |
Retained Earnings | -514.03 | -510.46 | -332.46 | -244.03 | -204.35 |
Comprehensive Income & Other | -0.16 | 10.81 | -0.17 | -0.03 | -0.03 |
Shareholders' Equity | -9.02 | -21.35 | 131.98 | 46.5 | 72.62 |
Total Liabilities & Equity | 9.94 | 8.23 | 163.13 | 58.3 | 84.63 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 1.49 | 10.17 | 3.79 | 5.78 | 7.02 |
Net Cash (Debt) | 0.22 | -9.69 | -3.57 | -3.9 | 2.16 |
Net Cash Growth | - | - | - | - | -83.86% |
Net Cash Per Share | 0.07 | -4.70 | -2.93 | -5.55 | 3.28 |
Filing Date Shares Outstanding | 5.03 | 2.9 | 1.95 | 0.82 | 0.7 |
Total Common Shares Outstanding | 4.62 | 2.22 | 1.94 | 0.8 | 0.66 |
Working Capital | -16.87 | -28.11 | -28.31 | -8.46 | 3.11 |
Book Value Per Share | -1.96 | -9.63 | 68.11 | 58.40 | 109.60 |
Tangible Book Value | -16.92 | -27.48 | -27.38 | -7.79 | -0.64 |
Tangible Book Value Per Share | -3.67 | -12.39 | -14.13 | -9.78 | -0.96 |
Machinery | 0.02 | 0.85 | 0.84 | 0.75 | 0.72 |
Leasehold Improvements | - | 0.22 | 0.22 | 0.22 | 0.22 |